Sodium-glucose cotransporter-2 inhibition in a CKD patient with severe heart failure treated by high-dose diuretics and peritoneal ultrafiltration: lesson for the clinical nephrologist

J Nephrol. 2024 Jan;37(1):199-201. doi: 10.1007/s40620-023-01766-x. Epub 2023 Sep 14.

Authors

Silvio Borrelli¹, Carlo Garofalo², Maria Elena Liberti¹, Chiara Ruotolo¹, Federica Capozzi¹, Pavlo Yavorskiy¹, Luca De Nicola¹

Affiliations

¹ Unit of Nephrology and Dialysis, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
² Unit of Nephrology and Dialysis, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy. carlo.garofalo@unicampania.it.

PMID: 37707693
DOI: 10.1007/s40620-023-01766-x

No abstract available

Keywords: Heart failure; Peritoneal dialysis; SGLT2-inhibitors.

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Diuretics / therapeutic use
Glucose
Heart Failure* / complications
Heart Failure* / drug therapy
Humans
Nephrologists
Renal Insufficiency, Chronic* / drug therapy
Renal Insufficiency, Chronic* / therapy
Sodium
Ultrafiltration

Substances

Diuretics
Glucose
Sodium